SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Benedicto David C.

(Last) (First) (Middle)
C/O ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, STE 300

(Street)
SAN DIEGO CA 92130

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/23/2021
3. Issuer Name and Ticker or Trading Symbol
Adamis Pharmaceuticals Corp [ ADMP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 6,387 D
Common Stock 50,645(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 12/01/2024 Common Stock 30,000 4.1 D
Employee Stock Option (right to buy) (3) 01/25/2026 Common Stock 18,811 4.1 D
Employee Stock Option (right to buy) (4) 02/07/2027 Common Stock 51,000 3.15 D
Employee Stock Option (right to buy) (5) 02/21/2028 Common Stock 104,333 2.83 D
Explanation of Responses:
1. Represents restricted stock units (RSUs) granted to the Reporting Person on January 30, 2019. Each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest ratably over a period of approximately three years with respect to approximately 1/12 of the total number of RSUs on each on May 17, August 17, November 17 and March 17 of each year, provided that the Reporting Person has continued to provide services to the Company during such period. The RSUs vest earlier in connection with a Change in Control of the Company (as defined in the Plan and the applicable award agreement) or upon the death or disability of the Reporting Person, and the shares covered by the RSU are issuable following vesting as provided in the Plan and award agreement. The RSUs are granted pursuant to the 2009 Equity Incentive Plan and are subject to other provisions in the applicable award agreement.
2. The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the December 1, 2014 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
3. The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the January 25, 2016 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
4. The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the February 07, 2017 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
5. The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the February 21, 2018 grant date, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Remarks:
/s/David C. Benedicto 06/02/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.